We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A pharmaceutical company in Beijing has received a warning letter from the FDA after barring investigators from the facility as well as falsifying and backdating records. Read More
The formal process for disputing a patent before the U.S. Patent and Trademark Office skirts statutory requirements and provides drugmakers with an unfair proceeding that skews outcomes, industry said. Read More
A federal judge in New Jersey has ruled that Merck’s patent infringement lawsuit against generic drug manufacturer Fresenius Kabi can proceed. Read More
Endo Pharmaceuticals is pushing to keep alive a lawsuit against it by the Federal Trade Commission in the U.S. District Court for the Eastern District of Pennsylvania. Read More